BOSTON, MA., April 3, 2024 – OrthoSpineNews – NanoHive Medical, LLC, an innovative 3D printing spinal implant technology company, has entered into a distribution agreement with HC Trade USA, a leading global medical distribution company, to represent NanoHive’s highly innovative Hive™ Soft Titanium® interbody fusion products portfolio in South American markets as well as other select international markets. The companies anticipate the first South American market sales in the upcoming second quarter of this year.
Patrick O’Donnell, President & CEO of NanoHive Medical stated, “NanoHive has made remarkable progress, particularly over the past twenty-four months, driving adoption of our technology and consistently growing our sales quarter-over-quarter primarily through our independent distribution channel in the U.S. market. We have reached the stage where it is now executable for us to enter new markets without disrupting our focus on managing rapid growth in the U.S. Based on their high caliber reputation and history of success in the spine device industry, we are very enthusiastic about the opportunity to partner with HC Trade USA on market entry and growth initiatives.”
Husnu Ceylan, President & CEO of HC Trade USA remarks, “Our markets are demanding next generation innovation at a reasonable price. We believe, having methodically assessed several products in this segment, that NanoHive’s Hive technology is significantly distinguishable and is an ideal solution for our surgeon customers. Our team is very excited to represent NanoHive’s products.”
About NanoHive Medical, LLC
NanoHive Medical is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices offers surgeons and their patients a set of exceptional characteristics, including optimal biomechanical elastic modulus properties, precise diagnostic imaging capabilities, and ideal osteoblast cell attraction and integration qualities. These features may consistently contribute to strong fusion constructs and positive clinical experiences.
NanoHive Medical is located in Woburn, Massachusetts U.S.A
Contact: Patrick O’Donnell, CEO & President, Patrick.odonnell@nanohive.com
Website: www.nanohive.com
About HC Trade USA
As an international medical and pharmaceutical product distribution company; HC Trade USA has more than 550 years of combined experience in global medical markets and has established a total global sales volume of $450M+ since 2006.
HC Trade USA has a wide and reputable network of manufacturers in the USA, Europe and Asia, which produce highly specialized medical and pharmaceutical products to satisfy the demand of our strategic partners’ local markets.
HC Trade USA is based in Miami, FL USA, with branch offices in Mexico, Colombia, Peru, Chile, Panama, Türkiye, UAE and South Korea, and mainly participates in government and military tenders. It has direct contacts in many private hospitals and medical clinics worldwide, spanning more than 60 countries.
Learn more at www.hctradeusa.com.
